![](/img/cover-not-exists.png)
MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients
M. Gittelman, P.J. Pommerville, B.E. Persson, T. Kold OlesenVolume:
70
Year:
2007
Language:
english
DOI:
10.1016/j.urology.2007.06.325
File:
PDF, 87 KB
english, 2007